The androgen receptor amino-terminal domain plays a key role in p160 coactivator-stimulated gene transcription.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMC 84524)

Published in Mol Cell Biol on September 01, 1999

Authors

P Alen1, F Claessens, G Verhoeven, W Rombauts, B Peeters

Author Affiliations

1: Division of Biochemistry, Faculty of Medicine, University of Leuven, B-3000 Leuven, Belgium.

Articles citing this

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res (2008) 6.33

Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO J (2002) 3.27

Alternatively spliced androgen receptor variants. Endocr Relat Cancer (2011) 2.41

Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylation. Proc Natl Acad Sci U S A (2007) 2.34

Recognition and accommodation at the androgen receptor coactivator binding interface. PLoS Biol (2004) 1.91

Androgen receptor signaling in prostate cancer development and progression. J Carcinog (2011) 1.90

Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function. Mol Cell Biol (2002) 1.48

Diverse roles of androgen receptor (AR) domains in AR-mediated signaling. Nucl Recept Signal (2008) 1.47

The ErbB3-binding protein Ebp1 suppresses androgen receptor-mediated gene transcription and tumorigenesis of prostate cancer cells. Proc Natl Acad Sci U S A (2005) 1.46

Heterogeneous expression and functions of androgen receptor co-factors in primary prostate cancer. Am J Pathol (2002) 1.41

Purification and identification of a novel complex which is involved in androgen receptor-dependent transcription. Mol Cell Biol (2003) 1.38

A novel inducible transactivation domain in the androgen receptor: implications for PRK in prostate cancer. EMBO J (2003) 1.32

Synergy between estrogen receptor alpha activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO Rep (2000) 1.32

Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochem J (2005) 1.27

Dimer-specific potentiation of NGFI-B (Nur77) transcriptional activity by the protein kinase A pathway and AF-1-dependent coactivator recruitment. Mol Cell Biol (2003) 1.24

Jun dimerization protein 2 functions as a progesterone receptor N-terminal domain coactivator. Mol Cell Biol (2002) 1.23

Specific structural motifs determine TRAP220 interactions with nuclear hormone receptors. Mol Cell Biol (2000) 1.23

FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment. Mol Endocrinol (2008) 1.17

Cyclin D3/CDK11p58 complex is involved in the repression of androgen receptor. Mol Cell Biol (2007) 1.16

Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol Biol Cell (2002) 1.11

Selective androgen receptor modulators in preclinical and clinical development. Nucl Recept Signal (2008) 1.11

Supervillin associates with androgen receptor and modulates its transcriptional activity. Proc Natl Acad Sci U S A (2002) 1.10

The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor. Mol Cell Endocrinol (2012) 1.01

Roles of steroid receptor coactivator (SRC)-1 and transcriptional intermediary factor (TIF) 2 in androgen receptor activity in mice. Proc Natl Acad Sci U S A (2005) 0.98

Identification of SRC3/AIB1 as a preferred coactivator for hormone-activated androgen receptor. J Biol Chem (2010) 0.98

Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif. J Biol Chem (2014) 0.94

Nuclear compartmentalization of N-CoR and its interactions with steroid receptors. Mol Cell Biol (2006) 0.93

The skeletal response to estrogen is impaired in female but not in male steroid receptor coactivator (SRC)-1 knock out mice. Bone (2007) 0.90

Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells. Mol Cancer (2007) 0.86

Regulation of androgen receptor-dependent transcription by coactivator MED1 is mediated through a newly discovered noncanonical binding motif. J Biol Chem (2011) 0.86

DNA recognition by the androgen receptor: evidence for an alternative DNA-dependent dimerization, and an active role of sequences flanking the response element on transactivation. Biochem J (2003) 0.86

Androgen receptor gene rearrangements: new perspectives on prostate cancer progression. Curr Drug Targets (2013) 0.85

Structural and functional relationships of the steroid hormone receptors' N-terminal transactivation domain. Steroids (2009) 0.84

Corepressor effect on androgen receptor activity varies with the length of the CAG encoded polyglutamine repeat and is dependent on receptor/corepressor ratio in prostate cancer cells. Mol Cell Endocrinol (2011) 0.83

The p160 coactivator PAS-B motif stabilizes nuclear receptor binding and contributes to isoform-specific regulation by thyroid hormone receptors. J Biol Chem (2009) 0.82

Two panels of steroid receptor luciferase reporter cell lines for compound profiling. Comb Chem High Throughput Screen (2011) 0.81

NBBS isolated from Pygeum africanum bark exhibits androgen antagonistic activity, inhibits AR nuclear translocation and prostate cancer cell growth. Invest New Drugs (2009) 0.81

The promise and perils of HDAC inhibitors in neurodegeneration. Ann Clin Transl Neurol (2014) 0.81

Therapeutic Rationales, Progresses, Failures, and Future Directions for Advanced Prostate Cancer. Int J Biol Sci (2016) 0.81

A novel androgen receptor amino terminal region reveals two classes of amino/carboxyl interaction-deficient variants with divergent capacity to activate responsive sites in chromatin. Endocrinology (2009) 0.81

Understanding nuclear receptors using computational methods. Drug Discov Today (2009) 0.80

New insights into the androgen-targeted therapies and epigenetic therapies in prostate cancer. Prostate Cancer (2011) 0.79

Androgen receptor polyglutamine repeat length affects receptor activity and C2C12 cell development. Physiol Genomics (2011) 0.77

MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2. Mol Cancer (2007) 0.77

Coactivator recruitment of AhR/ARNT1. Int J Mol Sci (2014) 0.76

Articles cited by this

The nuclear receptor superfamily: the second decade. Cell (1995) 24.99

The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell (1996) 16.57

A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (1997) 11.15

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell (1996) 11.02

The CBP co-activator is a histone acetyltransferase. Nature (1997) 10.91

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (1996) 10.81

Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem (1994) 10.75

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science (1995) 10.42

The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell (1998) 9.96

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell (1997) 8.72

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature (1997) 8.38

Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature (1998) 8.33

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science (1997) 8.05

Steroid receptor coactivator-1 is a histone acetyltransferase. Nature (1997) 6.15

TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J (1996) 4.96

A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Biol (1996) 4.69

Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69

Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev (1995) 4.22

The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J (1998) 3.64

RAC3, a steroid/nuclear receptor-associated coactivator that is related to SRC-1 and TIF2. Proc Natl Acad Sci U S A (1997) 3.52

Co-activators and co-repressors in the integration of transcriptional responses. Curr Opin Cell Biol (1998) 3.51

Nuclear receptor coactivators and corepressors. Mol Endocrinol (1996) 3.44

Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (1990) 3.37

GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol Cell Biol (1997) 3.26

The nuclear receptor ligand-binding domain: structure and function. Curr Opin Cell Biol (1998) 3.08

A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J (1992) 2.93

Atomic structure of progesterone complexed with its receptor. Nature (1998) 2.83

The histone acetylase PCAF is a nuclear receptor coactivator. Genes Dev (1998) 2.58

TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J Biol Chem (1997) 2.56

Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes. Proc Natl Acad Sci U S A (1998) 2.55

Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol Endocrinol (1998) 2.55

Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. Mol Endocrinol (1991) 2.54

Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J (1998) 2.44

Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen. Mol Endocrinol (1997) 2.42

Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res (1997) 2.41

Hormone-dependent coactivator binding to a hydrophobic cleft on nuclear receptors. Science (1998) 2.31

The steroid receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptors. J Biol Chem (1998) 2.08

Identification of two transcription activation units in the N-terminal domain of the human androgen receptor. J Biol Chem (1995) 2.02

Estrogen receptor activation function 1 works by binding p160 coactivator proteins. Mol Endocrinol (1998) 1.95

Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators. J Biol Chem (1997) 1.92

Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol Cell Biol (1997) 1.87

Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev (1996) 1.60

Identification of a novel RING finger protein as a coregulator in steroid receptor-mediated gene transcription. Mol Cell Biol (1998) 1.60

AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol (1997) 1.58

A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J Biol Chem (1998) 1.56

Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem (1995) 1.54

Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity. J Biol Chem (1998) 1.48

CREB-binding protein in androgen receptor-mediated signaling. Proc Natl Acad Sci U S A (1998) 1.47

Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator. Proc Natl Acad Sci U S A (1996) 1.43

Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. Endocrinology (1996) 1.28

Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer. Mol Endocrinol (1998) 1.27

Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. J Biol Chem (1993) 1.27

Transcriptional regulation by steroid hormones. Steroids (1996) 1.26

Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol Endocrinol (1998) 1.26

Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol (1999) 1.25

Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. Biochemistry (1997) 1.24

CREB binding protein is a coactivator for the androgen receptor and mediates cross-talk with AP-1. J Biol Chem (1998) 1.14

Using a eukaryotic GST fusion vector for proteins difficult to express in E. coli. Biotechniques (1997) 1.09

Nuclear receptors spring into action. Nat Struct Biol (1996) 1.08

The extreme C terminus of progesterone receptor contains a transcriptional repressor domain that functions through a putative corepressor. Proc Natl Acad Sci U S A (1996) 1.07

The receptor-associated coactivator 3 activates transcription through CREB-binding protein recruitment and autoregulation. J Biol Chem (1998) 1.04

Delineation of two distinct type 1 activation functions in the androgen receptor amino-terminal domain. J Biol Chem (1996) 1.00

An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors. J Biol Chem (1999) 1.00

Thyroid hormone response elements differentially modulate the interactions of thyroid hormone receptors with two receptor binding domains in the steroid receptor coactivator-1. J Biol Chem (1998) 1.00

Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2. Mol Cell Biol (1998) 0.98

Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor. Mol Endocrinol (1997) 0.93

The presence of a transcription activation function in the hormone-binding domain of androgen receptor is revealed by studies in yeast cells. FEBS Lett (1997) 0.89

Coactivators and corepressors as mediators of nuclear receptor function: an update. Mol Cell Endocrinol (1998) 0.87

Antibodies against synthetic peptides recognize the human and rat androgen receptor. J Steroid Biochem Mol Biol (1990) 0.84

Useful vectors for the two-hybrid system in mammalian cells. Biotechniques (1997) 0.84

Multiple receptor interaction domains of GRIP1 function in synergy. Nucleic Acids Res (1998) 0.83

Domain functions of the androgen receptor. J Steroid Biochem Mol Biol (1992) 0.81

Articles by these authors

The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence. J Biol Chem (1987) 3.55

Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol (1999) 2.23

The US3-encoded protein kinase from pseudorabies virus affects egress of virions from the nucleus. J Gen Virol (1995) 2.04

The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol (1999) 2.00

Selective DNA binding by the androgen receptor as a mechanism for hormone-specific gene regulation. J Steroid Biochem Mol Biol (2001) 1.53

Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI. J Virol (1996) 1.53

A lectin from elder (Sambucus nigra L.) bark. Biochem J (1984) 1.40

Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer (2000) 1.33

Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci U S A (1997) 1.28

LNCaP prostatic adenocarcinoma cells derived from low and high passage numbers display divergent responses not only to androgens but also to retinoids. J Steroid Biochem Mol Biol (1997) 1.27

Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. Mol Endocrinol (1999) 1.25

Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res (1997) 1.25

Inv(2)(p23q35) in anaplastic large-cell lymphoma induces constitutive anaplastic lymphoma kinase (ALK) tyrosine kinase activation by fusion to ATIC, an enzyme involved in purine nucleotide biosynthesis. Blood (2000) 1.24

Biosynthesis, primary structure and molecular cloning of snowdrop (Galanthus nivalis L.) lectin. Eur J Biochem (1991) 1.20

Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men. Osteoporos Int (2012) 1.19

The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. J Biol Chem (1996) 1.15

Alterations in thyroid status modulate apolipoprotein, hepatic triglyceride lipase, and low density lipoprotein receptor in rats. Endocrinology (1990) 1.14

Differential DNA binding by the androgen and glucocorticoid receptors involves the second Zn-finger and a C-terminal extension of the DNA-binding domains. Biochem J (1999) 1.13

The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am J Pathol (2001) 1.13

The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. Eur J Biochem (1976) 1.13

Change of specificity mutations in androgen-selective enhancers. Evidence for a role of differential DNA binding by the androgen receptor. J Biol Chem (2000) 1.12

Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene (2000) 1.11

Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology (1996) 1.11

Differences in DNA binding characteristics of the androgen and glucocorticoid receptors can determine hormone-specific responses. J Biol Chem (2000) 1.06

Androgen specificity of a response unit upstream of the human secretory component gene is mediated by differential receptor binding to an essential androgen response element. Mol Endocrinol (1999) 1.06

Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol (2001) 1.05

Spermatogenesis and sertoli cell activity in mice lacking sertoli cell receptors for follicle-stimulating hormone and androgen. Endocrinology (2008) 1.05

Detailed functional studies on androgen receptor mild mutations demonstrate their association with male infertility. Clin Endocrinol (Oxf) (2007) 1.02

Recombinant Newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy. Gene Ther (2007) 1.02

Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements. Mol Endocrinol (2004) 1.02

Production of monoclonal antibodies directed against antigenic determinants common to the alpha- and beta-chain of bovine brain S-100 protein. Lab Invest (1985) 1.01

Influence of nucleophosmin/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell. Oncogene (2007) 1.01

Molecular cloning, expression, and characterization of PTPA, a protein that activates the tyrosyl phosphatase activity of protein phosphatase 2A. J Biol Chem (1994) 1.01

Androgens and the control of lipid metabolism in human prostate cancer cells. J Steroid Biochem Mol Biol (1998) 1.01

Purification and characterisation of prostatic binding protein and its subunits. Eur J Biochem (1978) 1.00

The isolation and characterization of the vitamin D-binding protein from rat serum. J Biol Chem (1978) 0.99

Lipase-based quantitation of triacylglycerols in cellular lipid extracts: requirement for presence of detergent and prior separation by thin-layer chromatography. Lipids (1997) 0.98

Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli. Mol Biol Med (1986) 0.98

Functional characterization of an androgen response element in the first intron of the C3(1) gene of prostatic binding protein. Biochem Biophys Res Commun (1989) 0.98

Mechanisms of androgen receptor signalling via steroid receptor coactivator-1 in prostate. Endocr Relat Cancer (2004) 0.96

Acute treatment with corticosteroids decreases IGF-1 and IGF-2 expression in the rat diaphragm and gastrocnemius. Am J Respir Crit Care Med (1999) 0.96

The androgen receptor DNA-binding domain determines androgen selectivity of transcriptional response. Biochem Soc Trans (2006) 0.95

Effect of FSH on testicular morphology and spermatogenesis in gonadotrophin-deficient hypogonadal mice lacking androgen receptors. Reproduction (2010) 0.95

Interaction of the 90-kDa heat shock protein with native and in vitro translated androgen receptor and receptor fragments. Mol Cell Endocrinol (1992) 0.95

Prevalence of hip dysplasia, elbow dysplasia and humeral head osteochondrosis in dog breeds in Belgium. Vet Rec (2008) 0.95

Evaluation of B cell lymphoid infiltrates in bone marrow biopsies by morphology, immunohistochemistry, and molecular analysis. J Clin Pathol (2000) 0.94

Isolation and partial characterization of an N-acetylgalactosamine-specific lectin from winter-aconite (Eranthis hyemalis) root tubers. Biochem J (1985) 0.94

The differentiation-related gene 1, Drg1, is markedly upregulated by androgens in LNCaP prostatic adenocarcinoma cells. FEBS Lett (1999) 0.94

E2F activity is biphasically regulated by androgens in LNCaP cells. Biochem Biophys Res Commun (2001) 0.94

Musculoskeletal frailty: a geriatric syndrome at the core of fracture occurrence in older age. Calcif Tissue Int (2012) 0.93

Androgen receptor knockout and knock-in mouse models. J Mol Endocrinol (2008) 0.93

Isolation and characterization of a 5S RNA-protein complex from human placental ribosomes. Mol Biol Rep (1974) 0.93

Control of LNCaP proliferation and differentiation: actions and interactions of androgens, 1alpha,25-dihydroxycholecalciferol, all-trans retinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate (1996) 0.92

Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler Thromb (1991) 0.92

Fractionation of sialylated oligosaccharides, glycopeptides, and glycoproteins on immobilized elderberry (Sambucus nigra L.) bark lectin. Arch Biochem Biophys (1987) 0.92

Stimulation effect of neurotransmitters on the aromatization of testosterone by Sertoli cell-enriched cultures. Mol Cell Endocrinol (1979) 0.90

Direct action through the sertoli cells is essential for androgen stimulation of spermatogenesis. Endocrinology (2010) 0.90

Identification of diazepam-binding Inhibitor/Acyl-CoA-binding protein as a sterol regulatory element-binding protein-responsive gene. J Biol Chem (1998) 0.89

Influence of development, estrogens, and food intake on apolipoprotein A-I, A-II, and E mRNA in rat liver and intestine. J Lipid Res (1989) 0.89

Determination of the complete amino acid sequence of protein S21 from Escherichia coli ribosomes. Hoppe Seylers Z Physiol Chem (1975) 0.89

Molecular cloning and characterization of multiple isoforms of the snowdrop (Galanthus nivalis L.) lectin. Planta (1991) 0.89

A human gene encoding diazepam-binding inhibitor/acy1-CoA-binding protein: transcription and hormonal regulation in the androgen-sensitive human prostatic adenocarcinoma cell line LNCaP. DNA Cell Biol (1996) 0.88

Biochemical characterization of peritoneal fluid in women during the menstrual cycle. J Clin Endocrinol Metab (1980) 0.88

Androgen-receptor-specific DNA binding to an element in the first exon of the human secretory component gene. Biochem J (2001) 0.88

Identification of the phosphatidic acid phosphatase type 2a isozyme as an androgen-regulated gene in the human prostatic adenocarcinoma cell line LNCaP. J Biol Chem (1998) 0.88

Human androgen receptor expressed in HeLa cells activates transcription in vitro. Nucleic Acids Res (1994) 0.87

Differential innate responses of chickens and ducks to low-pathogenic avian influenza. Avian Pathol (2012) 0.87

Apolipoprotein A-IV messenger ribonucleic acid abundance is regulated in a tissue-specific manner. Endocrinology (1990) 0.86

The first exon of the human sc gene contains an androgen responsive unit and an interferon regulatory factor element. Mol Cell Endocrinol (1999) 0.86

Early effects of Sertoli cell-selective androgen receptor ablation on testicular gene expression. Int J Androl (2009) 0.86

Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle. J Hepatol (1998) 0.86